Efficacy, Safety and Tolerability of Vidofludimus in Patients With Inflammatory Bowel Disease: The ENTRANCE StudyKlaus Herrlinger, Eduard F. Stange, Mircea Diculescu et al.|Gastroenterology|2011Cited by 9
Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study.Ulrich Keilholz, Jérôme Fayette, Michael Schenker et al.|Journal of Clinical Oncology|2018Cited by 5